WN
The company develops a proprietary platform utilizing lipid-based particles for targeted drug delivery and diagnostic imaging in cancer therapies. This technology enables precise modification of treatments to selectively target cancer cells while preserving healthy tissue, addressing the critical need for effective therapies in high unmet need disease categories.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops a proprietary platform utilizing lipid-based particles for targeted drug delivery and diagnostic imaging in cancer therapies. This technology enables precise modification of treatments to selectively target cancer cells while preserving healthy tissue, addressing the critical need for effective therapies in high unmet need disease categories.